Dear Sir, Pursuant to SEBI (Prohibition of Insider Trading Regulations), 2015 as amended and in compliance with the terms of Code of Conduct of the Company, Please note that the Trading ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Omkar Pharmachem Ltd has informed BSE that the trading window for dealing in its securities will remain closed for designated persons and their immediate relatives starting July 1, 2025. The window will reopen 48 hours after the company declares its unaudited financial results for the quarter ended June 30, 2025 (Q1 FY26). The date of the board meeting to approve these results will be announced later. The communication was signed by Managing Director Bhawani Shankar Goyal and is filed in compliance with SEBI's Insider Trading Regulations, 2015.
This is a routine regulatory filing required before quarterly earnings and does not directly affect the stock price. However, it signals that the company's Q1 FY26 results announcement is approaching, which investors should watch for as the next potential catalyst.